The IMPC has several major funders and industry sponsors. All partners in the IMPC have their own funding streams, either in the form of grants or national funding.
As large majority of IMPC funding comes from the NIH. The NIH Knockout Mouse Programme (KOMP) project fund many of the centres. IMPC informatics and the data portal are supported by NIH grant U54 HG006370.
Other NIH grants include NIH U54706 HG006364; UM1 HG006348; U42 OD011174; U54 HG005348. NIH and OD, NCRR, NIDDK and NHLBI for KOMP and KOMP2 Projects U42 OD011175 and UM1OD023221.
The Infrafrontier project is funded by the EU and funds the infrastructure used by some members of the IMPC. Infrafrontier also funds annual conferences, jointly organised by the IMPC that showcase the latest research involving animal models.
Infrafrontier grant 01KX1012; EU Horizon2020: IPAD-MD funding 653961; EUCOMM: LSHM-CT-2005-018931, EUCOMMTOOLS: FP7-HEALTH-F4-2010-261492.
Some other grants funding IMPC
The Government of Canada through Genome Canada and Ontario Genomics (OGI-051) for NorCOMM2.
Wellcome Trust grants WT098051 and WT206194.
The French National Centre for Scientific Research (CNRS), the French National Institute of Health and Medical Research (INSERM), the University of Strasbourg and the “Centre Europeen de Recherche en Biomedecine”, and the French state funds through the “Agence Nationale de la Recherche” under the frame programme Investissements d’Avenir labelled (ANR-10-IDEX-0002-02, ANR-10-LABX-0030-INRT, ANR-10-INBS-07 PHENOMIN).